Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.
Zhu Y, Tang S, Yuan Q, Fu J, He J, Liu Z, Zhao X, Li Y, Zhao Y, Zhang Y, Zhang X, Zhang Y, Zhu Y, Wang W, Zheng B, Wu R, Wu T, Yang S, Qiu X, Shen S, Hu J, Chen L, Wang Y, Wang H, Gao D, Chen L.
Zhu Y, et al. Among authors: yuan q.
Cell Rep Med. 2024 Feb 20;5(2):101375. doi: 10.1016/j.xcrm.2023.101375. Epub 2024 Jan 25.
Cell Rep Med. 2024.
PMID: 38278146
Free PMC article.